This neuroinflammatory response may mediate tau‐related effects on cognition and behavior, suggesting that tau pathology not only drives cognitive decline but also influences the neuroinflammatory pathways that underlie NPS in AD. The gene discussed is MAPT; the disease is Alzheimer disease.